Positions

Overview

  • Dr. Ismail is a clinician-researcher who focuses on delivering comprehensive and optimal care for patients with inflammatory bowel disease. He completed his training in one of the largest inflammatory bowel disease centers in the United States (The Meyerhoff Inflammatory Bowel Disease Center at The Johns Hopkins University). He is comfortable in treating complex and medically refractory patients with inflammatory bowel disease. He is experienced in managing biologics and emerging therapies. Dr. Ismail's research focuses on understanding fibrosis and strictures development in Crohn's disease patients and the role of endotherapy in management.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.Inflammatory Bowel Diseases.  28:1265-1279. 2022
    2022 Impedance Planimetry for Crohn's Disease Anastomotic Stricture Characterization: A Predictor of Treatment Response?ACG Case Reports Journal.  9:e00729. 2022
    2022 Management of Crohn's stricture: medical, endoscopic and surgical therapies.Frontline Gastroenterology.  13:524-530. 2022
    2021 Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma.Journal of Hepatocellular Carcinoma.  8:701-711. 2021
    2020 ESD with double-balloon endoluminal intervention platform versus standard ESD for management of colon polyps.Endoscopy International Open.  8:E1273-E1279. 2020
    2020 Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinomaWorld Journal of Hepatology.  12:628-640. 2020
    2020 Retrospective analysis of long-term outcome 10 years after liver transplantation for Wilson disease: experience over three decadesTransplant International.  33:925-935. 2020
    2020 Identifying Barriers to the Treatment of Chronic Hepatitis C Infection.Digestive Diseases: clinical reviews.  38:46-52. 2020
    2019 The Benefits of a Local Kidney Exchange.Texas Heart Institute Journal.  46:71-72. 2019

    Research Overview

  • Inflammatory bowel disease, Crohn's disease, Ulcerative colitis
  • Principal Investigator On

    Education And Training

  • Bachelor of Medicine & Surgery (MBBS), Ain Shams University 2010
  • Full Name

  • Mohamed Ismail